Disclosed are novel proteins, referred to as tumor necrosis factor binding proteins, that modulate the activity of tumor necrosis factor. Also disclosed are processes for obtaining the tumor necrosis binding proteins by recombinant genetic engineering techniques.

 
Web www.patentalert.com

< Implantable device for treating atrial fibrillation and method of using same

< Transmyocardial revascularization system and method of use

> Bioabsorbable self-expanding stent

> Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
~ 00233